MoneyWorks4Me

Biocon has informs about investor meet

12 Dec 2019 Evaluate

Biocon has informed that pursuant to Regulation 30(6) of the SEBI Listing Regulations, a meeting was conducted with Institutional Investors / Analysts, Sunidhi Securities & Finance (Family Office) at Bangalore on December 12, 2019.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

397.25 -4.75 (-1.18%)
04-Sep-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1899.00
Dr. Reddys Labs. 1154.00
Cipla 1385.00
Lupin 2111.00
Zydus Lifesciences 1121.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: